Article
Why isn't an oncogenic mutation in KRAS enough to induce and sustain transformation?
Critical reviews in oncology/hematology - 1 Mar 2026
Iovanna Juan, Dusetti Nelson
Abstract excerpt
KRAS, a key member of the RAS proto-oncogene family, encodes a small GTPase involved in regulating cell proliferation, differentiation, and survival through signaling cascades such as MAPK/ERK, PI3K/AKT/mTOR, RalGEF/RalA/B, JAK/STAT3, and NF-κB. Although KRAS mutations, especially at codons 12, 13, or 61, lead to its activation and contribute to uncontrolled growth, these changes alone are not enough to fully...
Topics
Join the communities discussing this publication.
